RIPK1 antibody (AA 17-289)

Catalog No. ABIN7626019

This Mouse Monoclonal antibody specifically detects RIPK1 in WB, IHC, IP and ICC. It exhibits reactivity toward Human.

Quick Overview for RIPK1 antibody (AA 17-289) (ABIN7626019)

Target: RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This RIPK1 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Clone: C1

Product Details anti-RIPK1 Antibody

Binding Specificity: AA 17-289

Purpose: Receptor Interacting Serine Threonine Kinase 1 (RIPK1) Monoclonal Antibody

Sequence: Phe17~Tyr289

Characteristics: The Receptor Interacting Serine Threonine Kinase 1 (RIPK1) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.

Purification: Protein A + Protein G affinity chromatography

Isotype: IgG1 kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

Expiry Date: 12 months

Target Details for RIPK1

Target: RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))

Alternative Name: RIPK1

Gene ID: 8737

UniProt: Q13546

Pathways: NF-kappaB Signaling, Apoptosis, Caspase Cascade in Apoptosis, TLR Signaling, Activation of Innate immune Response, Inositol Metabolic Process, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling, SARS-CoV-2 Protein Interactome, Ubiquitin Proteasome Pathway